- Report
- October 2026
- 150 Pages
Global
From €4561EUR$4,850USD£3,805GBP
- Report
- January 2026
- 150 Pages
Japan
From €4561EUR$4,850USD£3,805GBP
- Report
- January 2026
- 150 Pages
India
From €4561EUR$4,850USD£3,805GBP
- Report
- October 2025
- 150 Pages
Germany
From €4561EUR$4,850USD£3,805GBP
- Report
- September 2025
- 150 Pages
China
From €4561EUR$4,850USD£3,805GBP
- Report
- August 2025
- 150 Pages
Global
From €4561EUR$4,850USD£3,805GBP
- Report
- August 2025
- 150 Pages
Global
From €4561EUR$4,850USD£3,805GBP
- Report
- April 2025
- 150 Pages
Global
From €4561EUR$4,850USD£3,805GBP
- Report
- March 2025
- 150 Pages
Global
From €4561EUR$4,850USD£3,805GBP
- Report
- March 2025
- 150 Pages
Global
From €4561EUR$4,850USD£3,805GBP
- Report
- March 2025
- 150 Pages
Global
From €4561EUR$4,850USD£3,805GBP
- Report
- November 2024
- 150 Pages
Global
From €4561EUR$4,850USD£3,805GBP
- Report
- October 2023
- 150 Pages
Global
From €4561EUR$4,850USD£3,805GBP
- Report
- September 2025
- 150 Pages
Canada
From €4561EUR$4,850USD£3,805GBP
- Report
- March 2025
- 150 Pages
Global
From €4561EUR$4,850USD£3,805GBP
- Report
- January 2024
- 150 Pages
Global
From €4561EUR$4,850USD£3,805GBP
- Report
- October 2025
- 160 Pages
Global
From €2972EUR$3,160USD£2,479GBP
€3715EUR$3,950USD£3,099GBP
- Report
- October 2025
- 160 Pages
Global
From €2972EUR$3,160USD£2,479GBP
€3715EUR$3,950USD£3,099GBP
- Report
- October 2025
- 160 Pages
Global
From €2972EUR$3,160USD£2,479GBP
€3715EUR$3,950USD£3,099GBP
- Report
- August 2025
- 150 Pages
Global
From €2972EUR$3,160USD£2,479GBP
€3715EUR$3,950USD£3,099GBP

Live attenuated vaccines are a type of vaccine that use a weakened form of a virus or bacteria to stimulate an immune response. These vaccines are designed to replicate the natural infection process, allowing the body to develop immunity without the risk of serious illness. Live attenuated vaccines are typically administered orally or nasally, and are often used to protect against diseases such as measles, mumps, rubella, and rotavirus.
Live attenuated vaccines are generally considered to be safe and effective, and are often used in combination with other vaccines to provide broader protection. They are also cost-effective, as they require fewer doses than other types of vaccines.
Notable companies in the live attenuated vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more